Immix Biopharma | Investor Presentation Deck | 64 slides · page 18 of 64
The chart illustrates the pharmacokinetics of the NXC-201 (HBI0101) therapy, highlighting a 30-day clearance window.
Deck · other · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 source-note 2/2 title 1/1
Components 4
line source-note source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.